12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Thursday. Notable gainers include Molecular Partners (MOLN), Zentalis Pharma (ZNTL), and Femasys (FEMY), while major losers include Mustang Bio (MBIO), Trevena (TRVN), and Sonnet BioTherapeutics (SONN).
June 20, 2024 | 4:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Mustang Bio (MBIO) shares declined by 28.9% to $0.6, reducing its market value to $17.0 million.
The significant price drop indicates negative investor sentiment, likely leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Sonnet BioTherapeutics (SONN) shares declined by 27.47% to $1.11, reducing its market value to $3.4 million.
The significant price drop indicates negative investor sentiment, likely leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Trevena (TRVN) stock declined by 28.9% to $0.25, with a market cap of $4.6 million.
The sharp decline in stock price suggests strong negative sentiment, likely leading to further short-term losses.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Femasys (FEMY) stock increased by 28.27% to $1.23, with a market value of $27.2 million.
The notable price increase indicates positive market sentiment, likely driving the stock price higher in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Molecular Partners (MOLN) stock rose 39.1% to $11.07, significantly increasing its market value to $367.3 million.
The substantial price increase indicates strong investor interest and positive sentiment, likely driving the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Zentalis Pharma (ZNTL) stock rose 36.83% to $5.67, increasing its market value to $402.2 million.
The significant price rise suggests strong investor confidence, likely leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100